Ingemar S J Merkies Selected Research

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

1/2022	Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy.
1/2022	Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post-hoc analysis of the immunoglobulin overtreatment in CIDP trial.
1/2022	Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
1/2021	Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy.
1/2020	Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review.
1/2019	Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.
1/2019	Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
1/2019	Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study.
3/2018	Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study).
1/2018	A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingemar S J Merkies Research Topics

Disease

24	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2022 - 02/2008
16	Small Fiber Neuropathy 10/2021 - 11/2012
15	Polyneuropathies (Polyneuropathy) 01/2022 - 04/2009
14	Pain (Aches) 01/2021 - 09/2011
8	Peripheral Nervous System Diseases (PNS Diseases) 11/2017 - 12/2010
4	Myotonic Dystrophy (Dystrophia Myotonica) 01/2021 - 07/2012
4	Painful Neuropathy 01/2020 - 11/2012
3	Guillain-Barre Syndrome 01/2021 - 12/2014
3	Channelopathies 11/2014 - 10/2012
2	Body Weight (Weight, Body) 01/2021 - 06/2013
2	Monoclonal Gammopathy of Undetermined Significance 09/2015 - 12/2014
2	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 06/2014 - 04/2013
1	Sudden Infant Death (SID) 01/2021
1	Diabetes Mellitus 01/2019
1	Clinical Deterioration 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2019
1	Erythromelalgia (Erythermalgia) 01/2017
1	Paroxysmal Extreme Pain Disorder 01/2017
1	Fabry Disease (Fabry's Disease) 01/2016
1	Fatigue 01/2016
1	Neuralgia (Stump Neuralgia) 10/2014
1	Sudden Death 07/2012
1	Cardiomyopathies (Cardiomyopathy) 07/2012
1	Diabetic Neuropathies (Diabetic Neuropathy) 09/2011
1	Chronic Disease (Chronic Diseases) 03/2011
1	Neoplasms (Cancer) 12/2010
1	Parkinson Disease (Parkinson's Disease) 01/2010

Drug/Important Bio-Agent (IBA)

24	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 02/2008
13	Sodium Channels (Sodium Channel)IBA 01/2020 - 10/2012
9	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 02/2012
8	HizentraIBA 01/2022 - 01/2016
7	Voltage-Gated Sodium ChannelsIBA 01/2020 - 10/2014
4	Immunoglobulin M (IgM)IBA 11/2017 - 12/2014
4	CaprylatesIBA 02/2012 - 02/2008
3	Lacosamide FDA Link 01/2020 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2020 - 03/2018
2	SodiumIBA 11/2014 - 06/2014
2	Prealbumin (Transthyretin)IBA 06/2014 - 04/2013
2	IceIBA 09/2010 - 02/2008
1	Saline SolutionIBA 01/2021
1	DexpramipexoleIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	PanzygaIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	NAV1.7 Voltage-Gated Sodium ChannelIBA 01/2016
1	alpha-Galactosidase (Beano)IBA 01/2016
1	Myelin-Associated GlycoproteinIBA 10/2015
1	SuspensionsIBA 10/2015
1	Arginine (L-Arginine)FDA Link 06/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2014
1	Analgesics (Analgesic Drugs)IBA 10/2014
1	Proline (L-Proline)FDA Link 06/2013
1	tafamidisIBA 04/2013
1	MD1IBA 07/2012
1	Indicators and Reagents (Reagents)IBA 03/2011
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 12/2010
1	rasagiline (Azilect)FDA Link 01/2010

Therapy/Procedure

14	Therapeutics 01/2022 - 02/2008
3	Activities of Daily Living (ADL) 01/2021 - 05/2020
3	Drug Therapy (Chemotherapy) 09/2015 - 12/2010
1	Drug Tapering 01/2018
1	Aftercare (After-Treatment) 10/2015
1	Spinal Cord Stimulation 09/2011